Strategic Growth BP3 Global is a mid-sized player (51-200 employees) with a revenue band of 50-100M, active in BPM, RPA, and AI. This presents a target for upsell into broader intelligent automation offerings, cross-sell with AI-driven process optimization, and expansion into larger enterprise deals as growth scales.

Strong Partnerships Recent and ongoing partnerships with Bell Integration and Camunda, plus recognition as EMEA Regional Partner of the Year, indicate a healthy partner ecosystem. Sales opportunities exist in co-selling together with tech partners, leveraging joint go-to-market to reach new enterprise customers.

Award-Winning IP Awards for Camunda Innovation Partner and NHS collaboration signal credibility in intelligent automation and healthcare. Target enterprise accounts in regulated industries seeking proven outcomes and reference-worthy deployments, especially where IDP and IPA capabilities are valued.

Acquisition Momentum Acquisition of Darwin Labs boosts low-code/no-code and IDP capabilities, expanding BP3’s technology stack. This creates opportunities to position BP3 as a one-stop shop for end-to-end automation, from process discovery to deployment on modern low-code platforms.

Global Expansion Recognition at Camunda Connect 2025 and NHS partnerships highlight traction across regions and industries. Pursue expansion into Europe and healthcare/government verticals, offering scalable BPM/RPA/AI solutions aligned with large-scale digital transformation programs.